1. Home
  2. EVGN vs CWD Comparison

EVGN vs CWD Comparison

Compare EVGN & CWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVGN
  • CWD
  • Stock Information
  • Founded
  • EVGN 1999
  • CWD 2009
  • Country
  • EVGN Israel
  • CWD United States
  • Employees
  • EVGN N/A
  • CWD N/A
  • Industry
  • EVGN Agricultural Chemicals
  • CWD Real Estate
  • Sector
  • EVGN Industrials
  • CWD Finance
  • Exchange
  • EVGN Nasdaq
  • CWD Nasdaq
  • Market Cap
  • EVGN 15.8M
  • CWD 13.4M
  • IPO Year
  • EVGN N/A
  • CWD 2023
  • Fundamental
  • Price
  • EVGN $2.72
  • CWD $0.54
  • Analyst Decision
  • EVGN Strong Buy
  • CWD
  • Analyst Count
  • EVGN 1
  • CWD 0
  • Target Price
  • EVGN $12.00
  • CWD N/A
  • AVG Volume (30 Days)
  • EVGN 23.0K
  • CWD 92.1K
  • Earning Date
  • EVGN 11-13-2024
  • CWD 11-07-2024
  • Dividend Yield
  • EVGN N/A
  • CWD N/A
  • EPS Growth
  • EVGN N/A
  • CWD N/A
  • EPS
  • EVGN N/A
  • CWD N/A
  • Revenue
  • EVGN $9,449,000.00
  • CWD $72,100,000.00
  • Revenue This Year
  • EVGN $173.12
  • CWD N/A
  • Revenue Next Year
  • EVGN $33.10
  • CWD $41.65
  • P/E Ratio
  • EVGN N/A
  • CWD N/A
  • Revenue Growth
  • EVGN 290.29
  • CWD N/A
  • 52 Week Low
  • EVGN $2.29
  • CWD $0.50
  • 52 Week High
  • EVGN $10.40
  • CWD $1.74
  • Technical
  • Relative Strength Index (RSI)
  • EVGN 39.48
  • CWD 39.65
  • Support Level
  • EVGN $2.63
  • CWD $0.51
  • Resistance Level
  • EVGN $3.07
  • CWD $0.76
  • Average True Range (ATR)
  • EVGN 0.26
  • CWD 0.07
  • MACD
  • EVGN 0.07
  • CWD -0.01
  • Stochastic Oscillator
  • EVGN 41.75
  • CWD 12.00

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.

About CWD CaliberCos Inc.

CaliberCos Inc is an asset management firm, whose primary goal is to enhance the wealth of investors seeking to make investments in middle-market assets. The company's funds include investment vehicles focused on real estate, private equity, and debt facilities. The company earns asset management fees calculated as a percentage of managed capital in funds and offerings. The company markets services through direct sales to private investors, wholesaling to investment advisers, direct sales to family offices and institutions and through in-house client services. The company operates into three reportable segments: Fund Management, Development, and Brokerage. Majority of revenue is derived from Asset management fees segment.

Share on Social Networks: